NDATOPICALSPONGE
Approved
Jul 2000
Lifecycle
LOE Approaching
Competitive Pressure
25/100
Data completeness
4/8 — Partial
CHLORAPREP ONE-STEP (chlorhexidine gluconate and isopropyl alcohol) by Becton Dickinson. Approved for bacteria. First approved in 2000.
Drug data last refreshed 22h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CHLORAPREP ONE-STEP is a topical antimicrobial sponge combining chlorhexidine gluconate and isopropyl alcohol for skin antisepsis. It is used to reduce bacteria on the skin prior to surgical procedures and other invasive medical interventions. The product works through the broad-spectrum bactericidal action of chlorhexidine and the rapid antimicrobial activity of isopropyl alcohol.
LOE Approaching7mo to LOE
Product is approaching loss of exclusivity with significant competitive pressure (25% intensity) and declining market opportunity, signaling reduced team investment and potential reorganization.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications (1)
Why This Matters for Your Career
Worked on CHLORAPREP ONE-STEP at Becton Dickinson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.